Live Oak Health Sciences Fund

3800 Embassy Parkway,Suite 310
Akron , OH, 44333-8334

Rank

Rank Universe
2 60

Summary

The fund seeks capital appreciation in the long term by investing in mid-and large-size companies in the United States.

The investment process is designed to highlight companies that are engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences.

Next, the research team considers pharmaceutical firms, designers and manufacturers of medical More

Link

Directors

Jan 11, 2024
  • Susan F. Akers
  • David J. Gruber
  • Michael R. Shade
  • James D. Oelschlager
  • Pauline F. Ramig

Chief Compliance Officer

  • Margaret L. Ballinger

Fund Manager(s)

  • James Oelschlager
  • Robert Stimpson
  • Jeffery Travis

Price

  • $ 20.28 ( -0.63 )
    Dec 27, 2024
    Last Close
  • Net Assets
  • $53.4M
    Apr 1, 2024
  • Holding
  • 33
    Sep 30, 2024
    More

  • 52-Week High/Low
  • $23.26 - $20.28
  • Turnover
  • 33%
  • Expense Ratio
  • 1.02%

Company Name

Holding

Mount Vernon Liquid Assets Portfolio, LLC 21.2 %
Regeneron Pharmaceuticals, Inc. 6.23 %
Mckesson Corp. 5.86 %
Amgen Inc. 5.34 %
Cencora Inc 4.81 %
Intuitive Surgical Inc. 4.02 %
The Cigna Group 3.91 %
Elevance Health Inc. 3.78 %
Thermo Fisher Scientific Inc 3.74 %
Exelixis, Inc. 3.56 %
More 3.56 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

-3.24%

5 Year

4.7%

Best

38.95%

2013

Worst

-32.43%

2002

Alpha

LOGSX S&P 500

Chart +